Understanding Clinical Trials and Their Role in Myelofibrosis is presented by Kristin Johnston, Chief Nursing Officer of Massive Bio. Kristin details the different aspects of oncology clinical trials and how they play a key role in the treatment of myelofibrosis. The full presentation is available to download at the bottom of the page.
The presentation reviews various topics such as:
- Summarize how clinical trials drive innovation, align with clinical pathways, and promote quality patient care
- The importance of clinical trials to treat myelofibrosis
- Recognize and describe the current challenges concerning Oncology Clinical Trials
- How Massive Bio’s Oncology Clinical Trial Command Center (OCTCC) can optimize enrollment for myelofibrosis and other oncology clinical trials
Myelofibrosis is a bone marrow cancer that affects the production of blood cells in the body and often leads to scarring of the bone marrow and anemia. Myelofibrosis belongs to a group of chronic blood disorders called Myeloproliferative Neoplasms (MPN). Some cases of myelofibrosis result from having other MPNs, which is called Secondary Myelofibrosis (SMF). When there are no prior MPNs to a myelofibrosis diagnosis, it is referred to as Primary Myelofibrosis (PMF).
Oncology clinical trials research new ways to improve the treatment of cancer patients of all stages and subtypes. For rare diseases like myelofibrosis, patient enrollment is especially important due to the lack of approved treatments currently available. By enrolling in oncology clinical trials, patients get early access to new and improved drugs to treat their cancer.
Massive Bio’s OCTCC can match patients with myelofibrosis and other cancer types to clinical trials using the AI-powered platform based on more than 100 data points including:
- Specific type of cancer
- Biomarker status
- Stage of disease
The full presentation for Understanding Clinical Trials and Their Role in Myelofibrosis is a helpful resource for providers, patients, and caregivers who are interested in learning more about oncology clinical trials and their impact in myelofibrosis patients.
To get access to Kristin’s full presentation on Understanding Clinical Trials and Their Role in Myelofibrosis, fill out the form below to download the file via email.
Click the button that best describes your reason for downloading the file between Medical Professional and Patient or Caregiver.